A phase I study of nab-paclitaxel (nP) with carboplatin (C) and thoracic radiation (TRT) in patients with locally advanced NSCLC.
V. L. Keedy
Research Funding - Abraxis BioScience
B. Lu
No relevant relationships to disclose
L. Horn
No relevant relationships to disclose
Y. Shyr
No relevant relationships to disclose
C. F. Winkler
No relevant relationships to disclose
D. P. Carbone
No relevant relationships to disclose
A. Sandler
Consultant or Advisory Role - Abraxis BioScience
Honoraria - Abraxis BioScience
Research Funding - Abraxis BioScience